Align Technology price target lowered to $325 from $370 at Baird

Baird lowered the firm’s price target on Align Technology to $325 from $370 and keeps an Outperform rating on the shares. With dental stocks underperforming the S&P 500 by 20 points year-to-date, “a lot of bad is clearly priced into the group,” the analyst tells investors in a research note. The firm says that while dental fundamentals remain challenging, investor sentiment “feels even more negative.” It believes “now is the time to tip-toe back into dental.”